Showing results (281-290 of 316) with videos related to

Sort By:
Pageof 32
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2012
[Role of French teams in the development of clinical and translational research in radiation oncology]D Azria, J-M Ardiet, B Chauvet, et al.
Bulletin Du Cancer|June 16, 2010
[Radiotherapy for sarcoma: hadrontherapy, for whom and what for?]P Pommier, M-P Sunyach, Yi Hu, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 23, 2024
[Characteristics of radiotherapy for adolescents and young adults]L Ollivier, A Laprie, E Jouglar, et al.
Bulletin Du Cancer|September 4, 2010
[Epidemiology and management of rare paediatric tumours within the framework of the French Society for Children Cancer]Y Réguerre, B Lacour, N André, et al.
Physical Review Letters|March 28, 2015
Controlling the spin of co atoms on pt(111) by hydrogen adsorptionQ Dubout, F Donati, C Wäckerlin, et al.
Revue Des Maladies Respiratoires|March 16, 2005
[Biomarkers as prognostic factors in pulmonary arterial hypertension. Rationale and study design]J L Cracowski, A Yaici, O Sitbon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 23, 2012
[Dosimetric and clinical benefits of respiratory-gated radiotherapy for lung and breast cancers: results of the STIC 2003]P Giraud, J Djadi-Prat, E Morvan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1G Robinet, P Thomas, J L Breton, et al.
The British Journal of Radiology|April 16, 2020
Mid-position treatment strategy for locally advanced lung cancer: a dosimetric studyM Ayadi, T Baudier, G Bouilhol, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 22, 2003
[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma]F Mornex, L Thomas, P Mohr, et al.
Pageof 32